CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Institute of Neuroscience, Howard Hughes Medical Institute, University of Oregon, Eugene, United States ...
Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results